The sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis: a unique therapeutic target in inflammatory bowel disease

Wang, J; Goren, I; Yang, B; Lin, SN; Li, JN; Elias, M; Fiocchi, C; Rieder, F

Rieder, F (通讯作者),Digest Dis & Surg Inst, Dept Gastroenterol Hepatol & Nutr, 9500 Euclid Ave, Cleveland, OH 44195 USA.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022; 55 (3): 277

Abstract

Background Ozanimod, a high selective sphingosine 1 phosphate (S1P) receptor (S1PR) 1/5 modulator was approved by the Food and Drug Administration for......

Full Text Link